EUVIMEDEUVIMED entdecken
Crossref

IgM Pemphigoid With Anti‐ BP180 C‐Terminal Autoantibodies Developing After Pembrolizumab and Enfortumab Vedotin Therapy

Hiroshi Koga, Ayaka Ohzono, Masahiro Tsutsumi, Sakura Maeda, Norito Ishii

The Journal of Dermatology · 18.11.2026

DOI: 10.1111/1346-8138.70578 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, online erschienen am 18.11.2026. Verfasst von Hiroshi Koga und 4 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Koga, H., Ohzono, A., Tsutsumi, M., Maeda, S., & Ishii, N. (2026). IgM Pemphigoid With Anti‐ BP180 C‐Terminal Autoantibodies Developing After Pembrolizumab and Enfortumab Vedotin Therapy. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70578

Vancouver

Koga H, Ohzono A, Tsutsumi M, Maeda S, Ishii N. IgM Pemphigoid With Anti‐ BP180 C‐Terminal Autoantibodies Developing After Pembrolizumab and Enfortumab Vedotin Therapy. The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70578

BibTeX
@article{Koga2026,
  author = {Koga, Hiroshi and Ohzono, Ayaka and Tsutsumi, Masahiro and Maeda, Sakura and Ishii, Norito},
  title = {IgM Pemphigoid With Anti‐ BP180 C‐Terminal Autoantibodies Developing After Pembrolizumab and Enfortumab Vedotin Therapy},
  journal = {The Journal of Dermatology},
  year = {2026},
  doi = {10.1111/1346-8138.70578}
}
Kostenlos starten →